All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

-

ISSN Print: 2059-0105

ISSN Online:

Website: https://www.nature.com/npjvaccines

Share:




Go

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines

Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus

Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen

A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease

A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs

OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes

From therapeutic antibodies to immune complex vaccines

Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology

Rabies-based vaccine induces potent immune responses against Nipah virus

Recent advances in the production of recombinant glycoconjugate vaccines

Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge

Plague vaccine: recent progress and prospects

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice

Turning the corner on therapeutic cancer vaccines

Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules

Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

Targeting of the Yersinia pestis F1 capsular antigen by innate-like B1b cells mediates a rapid protective response against bubonic plague

Raman spectroscopy-based identification of toxoid vaccine products

Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs

A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization

Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial

Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein

A Plasmodium berghei sporozoite-based vaccination platform against human malaria

An Ad/MVA vectored Theileria parva antigen induces schizont-specific CD8+ central memory T cells and confers partial protection against a lethal challenge

Using vaccine Immunostimulation/Immunodynamic modelling methods to inform vaccine dose decision-making

LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection

FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge

Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy

Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission

Gallid herpesvirus 3 SB-1 strain as a recombinant viral vector for poultry vaccination

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want

System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep

VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines

Generation of therapeutic antisera for emerging viral infections

Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations

Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein

Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties

Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development

A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection

The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial

Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates

Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years

Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

Selection and evaluation of an efficient method for the recovery of viral nucleic acids from complex biologicals

A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705